What is SION's operating cash flow?

SION (SION) reported operating cash flow of -$21.84M in Q1 2026.

How has SION's operating cash flow changed year-over-year?

SION's operating cash flow decreased by 34.1% year-over-year, from -$16.29M to -$21.84M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

SION SION Operating Cash Flow

Operating Cash Flow at other companies

Vertex PharmaceuticalsVRTX

$1.43B+74.4%

AbbVieABBV

$3.83B+134%

Septerna, Inc.SEPN

-$25.63M-9.8%

BioCryst PharmaceuticalsBCRX

-$61.79M-125%

Denali Therapeutics Inc.DNLI

-$131.2M+0.2%

Neurocrine BiosciencesNBIX

$145.8M+125%

Other financials

Income statement

See full

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

See full

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

See full

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

See full

Market cap$1.8B—

Enterprise value$1.74B—

Returns & leverage

See full

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SION's operating cash flow?: SION (SION) reported operating cash flow of -$21.84M in Q1 2026.
How has SION's operating cash flow changed year-over-year?: SION's operating cash flow decreased by 34.1% year-over-year, from -$16.29M to -$21.84M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.